Infertility is the inability of a man to give birth due to various reasons such as low sperm count, poor sperm motility or morphology, hormonal imbalances, anatomical abnormalities, genetics, diseases, diseases that are not land and life. Infertility affects about 15% of couples worldwide, with male infertility contributing to 30–40% of infertility. Low sperm count is one of the most common causes of male infertility. This can be due to many reasons, such as hormonal disorders, infections, varicocele (swelling of the veins that drain the testicle), and genetics. Improper sperm count and morphology can also affect male fertility, as sperm may not be able to swim properly or may not be formed properly for fertilization.
Lifestyle factors such as smoking, excessive alcohol consumption, drug use, obesity, and exposure to environmental toxins can also affect male fertility. Chronic diseases such as diabetes, high blood pressure and autoimmune diseases can also affect male fertility. The global Male Infertility Market was valued at $216 million, and is expected to reach $301.5 million by 2020, supported by a CAGR of 5%
Treatment for male infertility varies depending on the cause. In some cases, lifestyle changes, such as quitting smoking or losing weight, can improve fertility. In other cases, medical treatment such as hormone therapy or surgery may be necessary. Assisted reproductive technologies such as intrauterine insemination (IUI) and in vitro fertilization (IVF) can also be used to help couples conceive.
The growth of the male infertility market? The male infertility market is expected to grow significantly in the coming years. Factors contributing to this growth include the increasing incidence of male infertility, advances in diagnostic and treatment methods, and the increasing demand for reproductive technology (ART). According to a report from Allied Market Research, the global market value of male infertility is $3.1 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 4.2%. from 2021 to 2028. The report refers to growing. the demand for ART, increased public awareness of male infertility, and an increase in many life-enhancing factors that contribute to male fertility as a key factor in growth. . The market also benefits from an increasing number of collaborations between academic and research institutions, as well as pharmaceutical and biotechnology companies. These partnerships lead to the development of new and effective treatments for male infertility, increasing market growth. However, the cost of male infertility treatments and high insurance coverage for these treatments are expected to limit the market growth to some extent. However, in general, it is expected that the male infertility market will continue to grow as the rate of male infertility continues to rise and creating more effective treatments to address this growing problem. There is a continuous increase in the number of infertility around the world, in both developed and developing countries. Lifestyle changes, pregnancy and aging are some of the causes of infertility around the world. The report excludes the main treatments for male infertility such as surgery, treatment of sexual problems and hormone therapy. The article focuses on male infertility and its treatment with emphasis on drugs and devices. Different methods are used to diagnose male infertility such as DNA fragmentation, oxidative stress, CASA (computer assisted genetic analysis), sperm concentration test, sperm agglutination and microscopic examination. DNA sequencing is an emerging technique that has already gained popularity and is accepted as a practice in developed countries. The system has not gained popularity in the developing world and is not used as a daily routine due to financial constraints.
0 Comments